Hayward, California-based RefleXion Medical, a developer of biology-guided radiotherapy system for targeted cancer treatment, has raised more than $100 million in Series C funding. The Rise Fund, an impact investment fund managed by TPG Growth, led the round with participation from other investors that included T. Rowe Price Associates, Inc, GT Healthcare Capital Partners, Sofinnova Partners, KCK Group, Venrock, Pfizer Venture Investments and Johnson & Johnson Innovation – JJDC Inc.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: